Skip to content
IDDRIVE
  • Home
  • Study Contributors
  • Studies
  • Governance
  • Publications & Events
    • Study documents and tools
    • Publications
    • Events
  • Contact
  • Newsroom

Category: Publications

Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
24 February, 202624 February, 2026

Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform

Publications by Gert Verbeken0 comments

Hannah R. Volkman ,Leonie de Munter, Jennifer L. Nguyen, Thao M. P. Tran, Marianna Mitratza, Cátia Marques, Laura Choi, Srinivas […]

Read more>>
Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness Studies
14 October, 202514 October, 2025

Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness Studies

Publications by Gert Verbeken0 comments

Chloé Wyndham-Thomas, Leonie de Munter, Kok Yew Ngew, Sanskruti Gaikwad, Konstantina Chatzikonstantinidou, Antonio Carmona, Charlotte Martin, Gerrit Luit ten Kat, […]

Read more>>
Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study.
29 September, 202529 September, 2025

Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study.

Publications by id.DRIVE consortium0 comments

Chloé Wyndham-Thomas, E. Claire Newbern, Ainara Mira-Iglesias, Akshat Dwivedi, Alejandro Orrico Sánchez, Andrés Antón, Charlotte Martin, Giancarlo Icardi, Irma Casas, […]

Read more>>
Effectiveness of the AZD1222 Vaccine against COVID-19 hospitalisation in Europe: Final results from the COVIDRIVE test-negative case-control study. 
28 September, 202529 September, 2025

Effectiveness of the AZD1222 Vaccine against COVID-19 hospitalisation in Europe: Final results from the COVIDRIVE test-negative case-control study. 

Publications by Gert Verbeken0 comments

Leonie de Munter, Wilhelmine Meeraus, Akshat Dwivedi, Marianna Mitratza, Chloé Wyndham-Thomas, Lucy Carty, Mario Ouwens, Wendy Hartig-Merkel, Laura Drikite, Griet […]

Read more>>
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVEplatform.
27 September, 202529 September, 2025

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVEplatform.

Publications by Gert Verbeken0 comments

Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, Leonie de Munter, Thao Mai Phuong Tran, Catia Marques, Mustapha Mustapha, Srinivas […]

Read more>>
Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.
26 September, 202529 September, 2025

Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.

Publications by Gert Verbeken0 comments

Wilhelmine Meeraus, Leonie de Munter, Christen M. Gray, Akshat Dwivedi, Chloé Wyndham-Thomas, Mario Ouwens, Wendy Hartig-Merkel, Laura Drikite, Griet Rebry, […]

Read more>>
Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform” (pre-print).
25 September, 202529 September, 2025

Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform” (pre-print).

Publications by Gert Verbeken0 comments

HR Volkman, L de Munter, JL Nguyen, TMP Tran, M Mitratza, C Marques, L Choi, S Valluri, J Yang, A […]

Read more>>
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE – a European initiative
24 September, 202529 September, 2025

The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE – a European initiative

Publications by Gert Verbeken0 comments

Díez-Domingo J, Torcel-Pagnon L, Carmona A, Launay O, Dos Santos G, Rizzo C, Haag M, Stuurman A, Nauta J, Vannacci […]

Read more>>

© Copyright 2024   |   id.DRIVE   |   ALL RIGHTS RESERVED

 

Proudly powered by WordPress | Theme: Airi by aThemes.